Virtu Financial LLC

Position in OCGN — Ocugen, Inc.

CIK 1533964 New York, NY

Position in OCGN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,053,514

+$947,981 QoQ

Shares Held

582,052

+644.6% QoQ

Ownership

0.172%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Virtu Financial LLC holds $39,638,090 across 141 Biotechnology names. OCGN ranks #6 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	7,634	$3,408,886
2	BMRN	Biomarin Pharmaceutical Inc	38,479	$2,173,678
3	IBRX	ImmunityBio, Inc.	262,298	$2,011,825
4	ANAB	Anaptysbio, Inc	33,323	$1,848,091
5	ABVX	Abivax S.A.	9,551	$1,063,503
6	OCGN	Ocugen, Inc. This page	582,052	$1,053,514
7	IOVA	Iovance Biotherapeutics, Inc.	285,829	$1,003,259
8	PVLA	Palvella Therapeutics, Inc.	7,726	$963,045

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,053,514	582,052	+644.6%	Shares	Defined	2026-05-14
2025-12-31	$105,533	78,173	-60.4%	Shares	Defined	2026-02-23
2025-06-30	$191,431	197,352	+401.9%	Shares	Defined	2025-08-12
2024-12-31	$31,654	39,322	+8.5%	Shares	Defined	2025-02-11
2023-09-30	$14,492	36,232	-83.6%	Shares	Defined	2023-11-15
2023-06-30	$119,832	220,686	+60.9%	Shares	Defined	2023-07-27
2022-12-31	$178,305	137,158	+57.4%	Shares	Defined	2023-02-15
2022-09-30	$155,127	87,150	-5.2%	Shares	Defined	2022-11-07
2021-12-31	$418,413	91,959	+498.0%	Shares	Defined	2022-02-17
2020-06-30	$3,383	15,379	—	Shares	Defined	2020-08-07
No filing history on record for this holder in this stock.